Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial. (Q50561061)

From Wikidata

Jump to navigation Jump to search

scientific article published in August 1997

Language	Label	Description	Also known as
English	Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial.	scientific article published in August 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Treatment with verapamil and trandolapril in patients with congestive heart failure and angina pectoris or myocardial infarction. The DAVIT Study Group. Danish Verapamil Infarction Trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

0 references

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

congestive heart failure

1 reference

based on heuristic

inferred from title

author name string

Hansen JF

1

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Hagerup L

2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Sigurd B

3

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Pedersen F

4

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Mellemgaard K

5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Bjergaard OP

6

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

134

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

2 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

S48-52

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II--DAVIT II)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Calcium channel blockers in chronic heart failure. The risks of "physiologically rational" therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Secondary prevention with verapamil after myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

ACE inhibitors and calcium antagonists in the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Placebo controlled trial of felodipine in patients with mild to moderate heart failure. UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Usefulness of verapamil for congestive heart failure associated with abnormal left ventricular diastolic filling and normal left ventricular systolic performance

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Placebo-controlled evaluation of three doses of a controlled-onset, extended-release formulation of verapamil in the treatment of stable angina pectoris

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

The effect of verapamil on major events in patients with impaired cardiac function recovering from acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Prevalence of transient myocardial ischaemia during the first year after a myocardial infarction. Effect of treatment with verapamil. The Danish Study Group on Verapamil in Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Platelet aggregability in vivo is attenuated by verapamil but not by metoprolol in patients with stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction. The protective effects of captopril.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Reduction of ischemic events with angiotensin-converting enzyme inhibitors: lessons and controversy emerging from recent clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

ACE inhibitors after myocardial infarction: patient selection or treatment for all?

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Predictors and long-term prognostic significance of recurrent infarction in the year after a first myocardial infarction. SPRINT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

ACE inhibition, atherosclerosis and myocardial infarction--the AIRE Study in practice. Acute Infarction Ramipril Efficacy Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2897%2970008-5

7 January 2021

Identifiers

10.1016/S0002-8703(97)70008-5

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 March 2018

http://europepmc.org/abstract/MED/9313623

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50561061&oldid=1517761600"